FBInvestor
Stocks / Tonix Pharmaceuticals Hldg C
Institutional Ownership

Tonix Pharmaceuticals Hldg C

CUSIP 890260839COM NEWTNXPQ1 2026

13D / 13G Filings
6
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
9.2%
Max % of class reported
Institutional Holders
77
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

6 filings · latest Jan 30, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jan 30, 2026The Vanguard Group13G/A5.0%673.6KSEC
2Jan 21, 2026Blackrock, Inc.13G/A6.7%854.6KSEC
3Dec 31, 2025Point72 Asset Management, L.P.13G9.2%1.24MSEC
4Oct 31, 2025The Vanguard Group13G6.3%557.0KSEC
5Oct 17, 2025Blackrock, Inc.13G/A7.8%680.0KSEC
6Jul 17, 2025Blackrock, Inc.13G5.7%420.4KSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →